- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Co-Diagnostics Inc (CODX)
Co-Diagnostics Inc stock price live, this page displays NASDAQ CODX stock exchange data. View the CODX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Co-Diagnostics Inc real time stock price chart below.
What Is the Co-Diagnostics Inc Stock Price Today?
The Co-Diagnostics Inc stock price today is 0.285.
What Is the Stock Symbol for Co-Diagnostics Inc?
The stock symbol for Co-Diagnostics Inc is "CODX."
What Stock Exchange Does Co-Diagnostics Inc Trade On?
Co-Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Co-Diagnostics Inc a Good Stock to Buy?
Determining whether Co-Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CODX quote. (ISIN: US1897631057)
What Is the Co-Diagnostics Inc Stock Price Today?
The Co-Diagnostics Inc stock price today is 0.285.
What Is the Stock Symbol for Co-Diagnostics Inc?
The stock symbol for Co-Diagnostics Inc is "CODX."
What Stock Exchange Does Co-Diagnostics Inc Trade On?
Co-Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Co-Diagnostics Inc a Good Stock to Buy?
Determining whether Co-Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CODX quote. (ISIN: US1897631057)
0.285
+0.009(+3.37%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.271
0.290
52 wk Range
0.228
2.230
CODX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CODX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2710.290
52 wk Range
0.2282.230
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CODX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
5.500
Upside
+1,829.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Co-Diagnostics Company Profile
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
Co-Diagnostics Inc Earnings Call Summary for Q1/2025
- Q1 2025 net loss improved to $0.24/share from $0.31/share YoY, despite revenue drop to $100,000 from $500,000; stock up 4.14% after-hours
- Company maintains strong liquidity with 4.41 current ratio; plans clinical trials for diagnostic tests in 2025, aiming for FDA approval of COVID-19 test
- Strategic expansion in India with new manufacturing facility targeted for completion by year-end to strengthen presence in emerging markets
- CEO highlights potential of Kodiak PCR platform; CFO emphasizes capital securing strategy through equity financing and grants for growth initiatives
- Analysts focused on COVID-19 test submission timing and clinical trial schedules for TB, HPV, and respiratory panel tests during Q&A session
Last Updated: 09-05-2025, 03:36 am
Read Full TranscriptCompare CODX to Peers and Sector
Metrics to compare | CODX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCODXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −3.0x | −0.5x | |
PEG Ratio | −0.02 | 0.00 | 0.00 | |
Price/Book | 0.2x | 2.3x | 2.6x | |
Price / LTM Sales | 2.8x | 2.9x | 3.1x | |
Upside (Analyst Target) | - | 56.8% | 51.1% | |
Fair Value Upside | Unlock | 3.6% | 8.9% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.500
(+1,829.82% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.24 / -0.34
Revenue / Forecast
50.00K / 400.00K
FAQ
What Is the Co-Diagnostics (CODX) Stock Price Today?
The Co-Diagnostics stock price today is 0.29.
What Stock Exchange Does Co-Diagnostics Trade On?
Co-Diagnostics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Co-Diagnostics?
The stock symbol for Co-Diagnostics is "CODX."
What Is the Co-Diagnostics Market Cap?
As of today, Co-Diagnostics market cap is 9.61M.
What Is Co-Diagnostics's Earnings Per Share (TTM)?
The Co-Diagnostics EPS (TTM) is -1.16.
When Is the Next Co-Diagnostics Earnings Date?
Co-Diagnostics will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is CODX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Co-Diagnostics Stock Split?
Co-Diagnostics has split 0 times.
How Many Employees Does Co-Diagnostics Have?
Co-Diagnostics has 132 employees.
What is the current trading status of Co-Diagnostics (CODX)?
As of 16 Jun 2025, Co-Diagnostics (CODX) is trading at a price of 0.29, with a previous close of 0.28. The stock has fluctuated within a day range of 0.27 to 0.29, while its 52-week range spans from 0.23 to 2.23.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.